EVALUATION OF THE EFFECTIVENESS OF CHONDROPROTECTORS IN THE TREATMENT OF OSTEOARTHRITIS

Abstract

Abstract: Osteoarthritis (OA) is one of the most prevalent degenerative joint diseases, characterized by progressive cartilage degradation, joint pain, and functional limitation. Chondroprotectors, including glucosamine sulfate and chondroitin sulfate, have been widely used as therapeutic agents aimed at protecting cartilage, reducing inflammation, and improving joint function. This article aims to evaluate the clinical efficacy of chondroprotective agents in the management of osteoarthritis based on recent studies and clinical observations. Findings suggest that chondroprotectors may provide moderate pain relief and improve physical function in some patients, particularly during early stages of OA. However, variations in study results emphasize the need for standardized guidelines and further high-quality trials.